Connect with us
[bsa_pro_ad_space id=12]

Brownstone Institute

Vaccines Will Not and Cannot Make this Virus Endemic

Published

6 minute read

President Joe Biden’s repeated COVID-19 diagnosis is the latest data point showing our government’s “vaccine only” approach needs an immediate course correction. If four doses of a vaccine cannot protect the leader of the free world from infection, it is time to consider other tactics.

These measures should include generic medicines that have been dismissed by the mainstream medical community and media.

While Americans across the ideological spectrum wish the president recovery, we must take this moment to acknowledge that a strategy blindly focused on vaccinations is not getting the job done.

Don’t take my word for it. Use Biden’s own standard for success. Exactly one year before testing positive, the President declared, “You’re not going to get COVID if you have these vaccinations.” Back then, the seven-day average of new cases in the United States was around 50,000. Today, that number is estimated to be between 300,000-500,000 when considering ubiquitous and uncounted home testing, despite two-thirds of the population considered “fully vaccinated” by the CDC.

Yet the push for vaccines from the administration has continued unabated. Following Biden’s diagnosis, the White House tried to take a political victory lap. In their first press briefing following news of the diagnosis, White House press secretary Karine Jean-Pierre stressed the president’s vaccination status as, “what’s most important here.”

As a lifelong Democrat and medical doctor who has helped more than 700 patients recover from COVID-19 and its complications, I have seen the effectiveness of other treatment options with my own eyes. Take for instance, fluvoxamine, an inexpensive generic medicine typically associated with depression treatment. It costs $4 per pill, is readily available at pharmacies, and has demonstrated an effectiveness combating COVID-19 in large, randomized, controlled trials published in the Journal of the American Medical Association and the Lancet.

Yet two years after this data appeared, fluvoxamine is still getting the cold shoulder from the medical gatekeepers. Both the World Health Organization (WHO) and National Institutes of Health do not recommend its use against COVID-19.

Furthermore, medical professionals who deviate from the party line are callously dismissed by mainstream media outlets such as NPR, as “fringe medical doctors, natural healers and internet personalities ready to push unproven cures for COVID.”

Science and medicine are always changing for the better. Consider the incredible shifts in the landscape that occurred between the current president contracting the novel coronavirus and his predecessor. In October 2020, there were limited options available for President Donald Trump. Less than two years later, a nearly 80-year-old president was presumed to be on a path toward recovery on the day of his diagnosis.

Progress is a wonderful thing, but it’s only possible with an attitude of open-mindedness that challenges the status quo. Doctors and innovators should be incentivized to pursue and explore new and different approaches. Instead, we are being forced to adopt a group think or risk suffering the wrath of the establishment, or worse, loss of livelihood.

The powerful American Board of Internal Medicine, a sprawling organization with certification authority, has been issuing threatening letters to board-certified physicians with exemplary careers, accusing them of “misinformation” when their public assessments of the efficacy of generic, repurposed therapies contradict those of federal health agencies.

To be sure, demonstrably false “misinformation” can be dangerous, and a topic worthy of discussion. But with overwhelming evidence to support the statements in question, advocating different courses of action toward COVID-19 is far from misinformation. In fact, the suggestion from the White House that the vaccine lessened Biden’s symptoms more closely meets the standard for misinformation since it is an impossible standard to prove.

Of all people, Biden should be open to new ideas. He was elected with a clear mandate to implement a fresh approach toward the pandemic. Two summers ago, he castigated his predecessor, saying, “the president still does not have a plan.” He went on to say, “More than 170,000 Americans have died — by far the worst performance of any nation on Earth.”

Today, that number has — sadly — topped 1 million. Many more lives have been lost on this president’s watch than the last one. These are sobering statistics. Biden has fallen short of promise to “shut down” the virus.

It’s clear COVID-19 is going to be with us for the foreseeable future. How we address it is up to us. Now is the time for a change in approach. Let’s hope our elected leaders and medical professionals take heed.

Author

Pierre Kory is a Pulmonary and Critical Care Specialist, Teacher/Researcher. He is also the President and Chief Medical Officer of the non-profit organization Front Line COVID-19 Critical Care Alliance whose mission is to develop the most effective, evidence/expertise-based COVID-19 treatment protocols.

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Brownstone Institute

The Doctor Will Kill You Now

Published on

From the Brownstone Institute

Clayton-J-BakerClayton J. Baker, MD 

Way back in the B.C. era (Before Covid), I taught Medical Humanities and Bioethics at an American medical school. One of my older colleagues – I’ll call him Dr. Quinlan – was a prominent member of the faculty and a nationally recognized proponent of physician-assisted suicide.

Dr. Quinlan was a very nice man. He was soft-spoken, friendly, and intelligent. He had originally become involved in the subject of physician-assisted suicide by accident, while trying to help a patient near the end of her life who was suffering terribly.

That particular clinical case, which Dr. Quinlan wrote up and published in a major medical journal, launched a second career of sorts for him, as he became a leading figure in the physician-assisted suicide movement. In fact, he was lead plaintiff in a challenge of New York’s then-prohibition against physician-assisted suicide.

The case eventually went all the way to the US Supreme Court, which added to his fame. As it happened, SCOTUS ruled 9-0 against him, definitively establishing that there is no “right to die” enshrined in the Constitution, and affirming that the state has a compelling interest to protect the vulnerable.

SCOTUS’s unanimous decision against Dr. Quinlan meant that his side had somehow pulled off the impressive feat of uniting Antonin Scalia, Ruth Bader Ginsberg, and all points in between against their cause. (I never quite saw how that added to his luster, but such is the Academy.)

At any rate, I once had a conversation with Dr. Quinlan about physician-assisted suicide. I told him that I opposed it ever becoming legal. I recall he calmly, pleasantly asked me why I felt that way.

First, I acknowledged that his formative case must have been very tough, and allowed that maybe, just maybe, he had done right in that exceptionally difficult situation. But as the legal saying goes, hard cases make bad law.

Second, as a clinical physician, I felt strongly that no patient should ever see their doctor and have to wonder if he was coming to help keep them alive or to kill them.

Finally, perhaps most importantly, there’s this thing called the slippery slope.

As I recall, he replied that he couldn’t imagine the slippery slope becoming a problem in a matter so profound as causing a patient’s death.

Well, maybe not with you personally, Dr. Quinlan, I thought. I said no more.

But having done my residency at a major liver transplant center in Boston, I had had more than enough experience with the rather slapdash ethics of the organ transplantation world. The opaque shuffling of patients up and down the transplant list, the endless and rather macabre scrounging for donors, and the nebulous, vaguely sinister concept of brain death had all unsettled me.

Prior to residency, I had attended medical school in Canada. In those days, the McGill University Faculty of Medicine was still almost Victorian in its ways: an old-school, stiff-upper-lip, Workaholics-Anonymous-chapter-house sort of place. The ethic was hard work, personal accountability for mistakes, and above all primum non nocere – first, do no harm.

Fast forward to today’s soft-core totalitarian state of Canada, the land of debanking and convicting peaceful protesterspersecuting honest physicians for speaking obvious truth, fining people $25,000 for hiking on their own property, and spitefully seeking to slaughter harmless animals precisely because they may hold unique medical and scientific value.

To all those offenses against liberty, morality, and basic decency, we must add Canada’s aggressive policy of legalizing, and, in fact, encouraging industrial-scale physician-assisted suicide. Under Canada’s Medical Assistance In Dying (MAiD) program, which has been in place only since 2016, physician-assisted suicide now accounts for a terrifying 4.7 percent of all deaths in Canada.

MAiD will be permitted for patients suffering from mental illness in Canada in 2027, putting it on par with the Netherlands, Belgium, and Switzerland.

To its credit, and unlike the Netherlands and Belgium, Canada does not allow minors to access MAiD. Not yet.

However, patients scheduled to be terminated via MAiD in Canada are actively recruited to have their organs harvested. In fact, MAiD accounts for 6 percent of all deceased organ donors in Canada.

In summary, in Canada, in less than 10 years, physician-assisted suicide has gone from illegal to both an epidemic cause of death and a highly successful organ-harvesting source for the organ transplantation industry.

Physician-assisted suicide has not slid down the slippery slope in Canada. It has thrown itself off the face of El Capitan.

And now, at long last, physician-assisted suicide may be coming to New York. It has passed the House and Senate, and just awaits the Governor’s signature. It seems that the 9-0 Supreme Court shellacking back in the day was just a bump in the road. The long march through the institutions, indeed.

For a brief period in Western history, roughly from the introduction of antibiotics until Covid, hospitals ceased to be a place one entered fully expecting to die. It appears that era is coming to an end.

Covid demonstrated that Western allopathic medicine has a dark, sadistic, anti-human side – fueled by 20th-century scientism and 21st-century technocratic globalism – to which it is increasingly turning. Physician-assisted suicide is a growing part of this death cult transformation. It should be fought at every step.

I have not seen Dr. Quinlan in years. I do not know how he might feel about my slippery slope argument today.

I still believe I was correct.

Continue Reading

Brownstone Institute

Trump Covets the Nobel Peace Prize

Published on

From the Brownstone Institute

By Ramesh ThakurRamesh Thakur 

Many news outlets reported the announcement of the Nobel Peace Prize on Friday by saying President Donald Trump had missed out (Washington Post,  YahooHindustan TimesHuffington Post), not won (USA Today), fallen short (AP News), lost (Time), etc. There is even a meme doing the rounds about ‘Trump Wine.’ ‘Made from sour grapes,’ the label explains, ‘This is a full bodied and bitter vintage guaranteed to leave a nasty taste in your mouth for years.’

For the record, the prize was awarded to María Corina Machado for her courageous and sustained opposition to Venezuela’s ruling regime. Trump called to congratulate her. Given his own attacks on the Venezuelan president, his anger will be partly mollified, and he could even back her with practical support. He nonetheless attacked the prize committee, and the White House assailed it for putting politics before peace.

He could be in serious contention next year. If his Gaza peace plan is implemented and holds until next October, he should get it. That he is unlikely to do so is more a reflection on the award and less on Trump.

So He Won the Nobel Peace Prize. Meh!

Alfred Nobel’s will stipulates the prize should be awarded to the person who has contributed the most to promote ‘fraternity between nations…abolition or reduction of standing armies and…holding and promotion of peace congresses.’ Over the decades, this has expanded progressively to embrace human rights, political dissent, environmentalism, race, gender, and other social justice causes.

On these grounds, I would have thought the Covid resistance should have been a winner. The emphasis has shifted from outcomes and actual work to advocacy. In honouring President Barack Obama in 2009, the Nobel committee embarrassed itself, patronised him, and demeaned the prize. His biggest accomplishment was the choice of his predecessor as president: the prize was a one-finger send-off to President George W. Bush.

There have been other strange laureates, including those prone to wage war (Henry Kissinger, 1973), tainted through association with terrorism (Yasser Arafat, 1994), and contributions to fields beyond peace, such as planting millions of trees. Some laureates were subsequently discovered to have embellished their record, and others proved to be flawed champions of human rights who had won them the treasured accolade.

Conversely, Mahatma Gandhi did not get the prize, not for his contributions to the theory and practice of non-violence, nor for his role in toppling the British Raj as the curtain raiser to worldwide decolonisation. The sad reality is how little practical difference the prize has made to the causes it espoused. They bring baubles and honour to the laureates, but the prize has lost much of its lustre as far as results go.

Trump Was Not a Serious Contender

The nomination processes start in September and nominations close on 31 January. The five-member Norwegian Nobel committee scrutinises the list of candidates and whittles it down between February and October. The prize is announced on or close to 10 October, the date Alfred Nobel died, and the award ceremony is held in Oslo in early December.

The calendar rules out a newly elected president in his first year, with the risible exception of Obama. The period under review was 2024. Trump’s claims to have ended seven wars and boasts of ‘nobody’s ever done that’ are not taken seriously beyond the narrow circle of fervent devotees, sycophantic courtiers, and supplicant foreign leaders eager to ingratiate themselves with over-the-top flattery.

Trump Could Be in Serious Contention Next Year

Trump’s 20-point Gaza peace plan falls into three conceptual-cum-chronological parts: today, tomorrow, and the day after. At the time of writing, in a hinge moment in the two-year war, Israel has implemented a ceasefire in Gaza, Hamas has agreed to release Israeli hostages on 13-14 October, and Israel will release around 2,000 Palestinian prisoners (today’s agenda). So why are the ‘Ceasefire Now!’ mobs not out on the streets celebrating joyously instead of looking morose and discombobulated? Perhaps they’ve been robbed of the meaning of life?

The second part (tomorrow) requires Hamas demilitarisation, surrender, amnesty, no role in Gaza’s future governance, resumption of aid deliveries, Israeli military pullbacks, a temporary international stabilisation force, and a technocratic transitional administration. The third part, the agenda for the day after, calls for the deradicalisation of Gaza, its reconstruction and development, an international Peace Board to oversee implementation of the plan, governance reforms of the Palestinian Authority, and, over the horizon, Palestinian statehood.

There are too many potential pitfalls to rest easy on the prospects for success. Will Hamas commit military and political suicide? How can the call for democracy in Gaza and the West Bank be reconciled with Hamas as the most popular group among Palestinians? Can Israel’s fractious governing coalition survive?

Both Hamas and Israel have a long record of agreeing to demands under pressure but sabotaging their implementation at points of vulnerability. The broad Arab support could weaken as difficulties arise. The presence of the internationally toxic Tony Blair on the Peace Board could derail the project. Hamas has reportedly called on all factions to reject Blair’s involvement. Hamas official Basem Naim, while thanking Trump for his positive role in the peace deal,  explained that ‘Palestinians, Arabs and Muslims and maybe a lot [of] people around the world still remember his [Blair’s] role in causing the killing of thousands or millions of innocent civilians in Afghanistan and Iraq.’

It would be a stupendous achievement for all the complicated moving parts to come together in stable equilibrium. What cannot and should not be denied is the breathtaking diplomatic coup already achieved. Only Trump could have pulled this off.

The very traits that are so offputting in one context helped him to get here: narcissism; bullying and impatience; bull in a china shop style of diplomacy; indifference to what others think; dislike of wars and love of real estate development; bottomless faith in his own vision, negotiating skills, and ability to read others; personal relationships with key players in the region; and credibility as both the ultimate guarantor of Israel’s security and preparedness to use force if obstructed. Israelis trust him; Hamas and Iran fear him.

The combined Israeli-US attacks to degrade Iran’s nuclear capability underlined the credibility of threats of force against recalcitrant opponents. Unilateral Israeli strikes on Hamas leaders in Qatar highlighted to uninvolved Arabs the very real dangers of continued escalation amidst the grim Israeli determination to rid themselves of Hamas once and for all.

Trump Is Likely to Be Overlooked

Russia has sometimes been the object of the Nobel Peace Prize. The mischievous President Vladimir Putin has suggested Trump may be too good for the prize. Trump’s disdain for and hostility to international institutions and assaults on the pillars of the liberal international order would have rubbed Norwegians, among the world’s strongest supporters of rules-based international governance, net zero, and foreign aid, the wrong way.

Brash and public lobbying for the prize, like calling the Norwegian prime minister, is counterproductive. The committee is fiercely independent. Nominees are advised against making the nomination public, let alone orchestrating an advocacy campaign. Yet, one laureate is believed to have mobilised his entire government for quiet lobbying behind the scenes, and another to have bad-mouthed a leading rival to friendly journalists.

Most crucially, given that Scandinavian character traits tip towards the opposite end of the scale, it’s hard to see the committee overlooking Trump’s loud flaws, vanity, braggadocio, and lack of grace and humility. Trump supporters discount his character traits and take his policies and results seriously. Haters cannot get over the flaws to seriously evaluate policies and outcomes. No prizes for guessing which group the Nobel committee is likely to belong to. As is currently fashionable to say when cancelling someone, Trump’s values do not align with those of the committee and the ideals of the prize.

Author

Ramesh Thakur

Ramesh Thakur, a Brownstone Institute Senior Scholar, is a former United Nations Assistant Secretary-General, and emeritus professor in the Crawford School of Public Policy, The Australian National University.

Continue Reading

Trending

X